Newsroom

Nosis Bio CEO to lead panel discussion at California Life Sciences Summit on the Power of AI in Pharma R&D

Nosis Bio CEO to speak at Bay Area Biotech Forum on How AI in Changing Pharma R&D

Nosis Bio Head of Research and Principal Scientist to Present Research on Targeted siRNA Delivery at Oligotherapeutic Society Meeting 2024

Nosis Bio to Present Accepted Abstract on RNA Medicine for Pulmonary Disease at the 2024 European Respiratory Symposium

Nosis Bio SVP, Research & Development to chair session on Next Generation RNA technologies at the Annual RNA Leaders Congress

Nosis Bio Head of Research to Speak at 2024 Cystic Fibrosis Research Conference

Nosis Bio Principal Scientist to give Selected Talk at 2023 Annual Oligotherapeutics Society Meeting

Nosis Bio Head of Research to speak at 2nd Annual Non-viral Delivery Conference

Nosis Bio speaks with AWS about Using Generative AI to Shift Pharma R&D

Nosis Bio announces collaboration with Cystic Fibrosis Foundation for Cell-specific Gene Therapy

Nosis Bio is one of 21 startups accepted into the AWS Generative AI Accelerator

Nosis Bio is a recipient of the second Golden Ticket Award at Bakar Labs, sponsored by the AbbVie

Nosis Bio is a recipient of the first ever Golden Ticket Award at Bakar Labs, sponsored by the Cystic Fibrosis Foundation